All stock lists
Novartis AG (New York Stock Exchange:NVS)
CH · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - General
153.81+2.69 (+1.78%)
Insider Score
––Not scored
NVS Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Congress Trading
Recent trades of NVS by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Kevin HernHouse / R | Sale$15.00K – $50.00K | Aug 27, 2026 |
| Alan ArmstrongSenate / R | Purchase$1.00K – $15.00K | Mar 31, 2026 |
| Alan ArmstrongSenate / R | Purchase$15.00K – $50.00K | Mar 30, 2026 |
| Sheldon WhitehouseSenate / D | Sale$1.00K – $15.00K | Apr 9, 2024 |
| Sheldon WhitehouseSenate / D | Purchase$15.00K – $50.00K | Sep 20, 2023 |
| Kevin HernHouse / R | Sale$1.00K – $15.00K | Jan 31, 2023 |
| Kevin HernHouse / R | Sale$1.00K – $15.00K | Jan 30, 2023 |
| Alan LowenthalHouse | Sale$15.00K – $50.00K | Nov 23, 2020 |
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
NVS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NVS patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NVS from public contracts
Source: USAspending.gov
Recently reported changes in NVS holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing NVS, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
KH | House | Sell | $15.00K – $50.00K | Aug 27, 2026 |
| Senate | Buy | $1.00K – $15.00K | Mar 31, 2026 | |
| Senate | Buy | $15.00K – $50.00K | Mar 30, 2026 | |
| Senate | Sell | $1.00K – $15.00K | Apr 9, 2024 | |
| Senate | Buy | $15.00K – $50.00K | Sep 20, 2023 | |
| House | Sell | $1.00K – $15.00K | Jan 31, 2023 | |
| House | Sell | $1.00K – $15.00K | Jan 30, 2023 | |
| House | Sell | $15.00K – $50.00K | Nov 23, 2020 | |
| House | Sell | $1.00K – $15.00K | Nov 23, 2020 | |
| House | Buy | $1.00K – $15.00K | Jul 27, 2020 | |
| House | Buy | $1.00K – $15.00K | Jul 26, 2020 | |
| Senate | Sell | $1.00K – $15.00K | Apr 5, 2019 | |
| House | Buy | $15.00K – $50.00K | Feb 15, 2019 | |
| House | Buy | $1.00K – $15.00K | Feb 15, 2019 | |
| House | Buy | $50.00K – $100.00K | Feb 15, 2019 | |
| Senate | Buy | $1.00K – $15.00K | Jan 25, 2019 | |
| Senate | Sell | $1.00K – $15.00K | Dec 7, 2018 | |
| House | Buy | $50.00K – $100.00K | Nov 30, 2018 | |
| House | Buy | $1.00K – $15.00K | Nov 30, 2018 | |
| House | Buy | $15.00K – $50.00K | Nov 30, 2018 | |
| House | Buy | $50.00K – $100.00K | Nov 29, 2018 | |
| House | Buy | $1.00K – $15.00K | Nov 29, 2018 | |
| House | Buy | $15.00K – $50.00K | Nov 29, 2018 | |
| Senate | Buy | $1.00K – $15.00K | Mar 31, 2016 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.